A promoter polymorphism in CD36 is associated with an atherogenic lipid profile in a French general population

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Febbraio M
        • Hajjar D.P
        • Silverstein R.L
        CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.
        J. Clin. Invest. 2001; 108: 785-791
        • Aitman T.J
        • Glazier A.M
        • Wallace C.A
        • et al.
        Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.
        Nat. Genet. 1999; 21: 76-83
        • Kuniyasu A
        • Ohgami N
        • Hayashi S
        • Miyazaki A
        • Horiuchi S
        • Nakayama H
        CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes.
        FEBS Lett. 2003; 537: 85-90
        • Tsukamoto K
        • Kinoshita M
        • Kojima K
        • et al.
        Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progression to foam cells from macrophages.
        J. Atheroscler. Thromb. 2002; 9: 57-64
        • Kincer J.F
        • Uittenbogaard A
        • Dressman J
        • et al.
        Hypercholesterolemia promotes a CD36-dependent and endothelial nitric-oxide synthase-mediated vascular dysfunction.
        J. Biol. Chem. 2002; 277: 23525-23533
        • Shaul P.W
        Endothelial nitric oxide synthase.
        J. Physiol. 2003; 547: 21-33
        • Yamauchi T
        • Kamon J
        • Waki H
        • et al.
        The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.
        Nat. Med. 2001; 7: 941-946